For research use only. Not for therapeutic Use.
Balofloxacin(Cat No.:A000522)is a fluoroquinolone antibiotic primarily used to treat bacterial infections, particularly those affecting the urinary tract. It works by inhibiting bacterial DNA gyrase and topoisomerase IV, essential enzymes for DNA replication and transcription, leading to bacterial cell death. Known for its efficacy against Gram-negative bacteria like Escherichia coli and Klebsiella pneumoniae, Balofloxacin is also effective against certain Gram-positive strains. Its favorable pharmacokinetics and antibacterial spectrum make it a valuable option in managing persistent or resistant infections, especially in urinary and respiratory tract infections.
Catalog Number | A000522 |
CAS Number | 127294-70-6 |
Synonyms | 127294-70-6; 1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-(methylamino)piperidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; Balofloxacin [INN]; Baloxin; Q 35 |
Molecular Formula | C20H24FN3O4 |
Purity | ≥95% |
Target | Bacterial |
Solubility | Soluble in DMSO > 10 mM |
Storage | -20°C |
IUPAC Name | 1-cyclopropyl-6-fluoro-8-methoxy-7-[3-(methylamino)piperidin-1-yl]-4-oxoquinoline-3-carboxylic acid |
InChI | InChI=1S/C20H24FN3O4/c1-22-11-4-3-7-23(9-11)17-15(21)8-13-16(19(17)28-2)24(12-5-6-12)10-14(18(13)25)20(26)27/h8,10-12,22H,3-7,9H2,1-2H3,(H,26,27) |
InChIKey | MGQLHRYJBWGORO-UHFFFAOYSA-N |
SMILES | CNC1CCCN(C1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F |
Reference | 1: Chen XH, Zhang BW, Li H, Peng XX. Myo-inositol improves the host/’s ability to 2: Jiang H, Han S, Guo C, Liu T, Wu X. In vitro and in vivo effectiveness 3: Li H, Pan JY, Liu XJ, Gao JX, Wu HK, Wang C, Peng XX. Alterations of protein 4: Li P, Liu X, Li H, Peng XX. Downregulation of Na(+)-NQR complex is essential 5: Feng LS, Liu ML, Wang B, Chai Y, Hao XQ, Meng S, Guo HY. Synthesis and in 6: Betanzos-Cabrera G, Juárez-Verdayes MA, González-González G, Cancino-Díaz ME, 7: Deng J, Xiao Z, Zhang H, Zhang M, Tang J. [Determination of balofloxacin in 8: Bian Z, Tian Y, Zhang Z, Xu F, Li J, Cao X. High performance liquid 9: Yan ZY, Shao XF, Jiang XM, Hu YZ. [Studies on the reaction of balofloxacin 10: Seop Kim D, Kim KS, Hwan Choi K, Na H, Kim JI, Shin WH, Kim EJ. |